Table 2.
Number and prevalence of FVL, FII, and MTHFR in the cases and normal controls.
| FVL n (%) | FII n (%) | MTHFR n (%) | ||
|---|---|---|---|---|
| Cases | All cases n = 329 | 77(23.4%) | 11 (3.3%) | 21(6.4%) |
| Consang. n = 109 | 28 (25.7%) | 4 (3.7%) | 8 (7.3%) | |
| Non-consang. n = 220 | 49 (22.3%) | 7 (3.2%) | 13 (5.9%) | |
| RPL n = 309 | 70 (22.7%) | 11 (3.6%) | 20(6.5%) | |
| SB n = 65 | 20 (30.8%) | 4 (6.2%) | 2(3.1%) | |
|
| ||||
| Controls | All controls n = 402 | 73 (18.2%) | 17 (4.2%) | 43(10.7%) |
| Consang. n = 99 | 21 (21.2%) | 7 (7.0%) | 11 (11.1%) | |
| Non-consang. n = 303 | 52 (17.1%) | 10 (3.3%) | 32 (10.6%) | |
(i) n = number, (%) = prevalence, consang. = consanguineous, non-consang. = non-consanguineous.(ii) RPL: all cases excluding those with only stillbirth, SB: cases with stillbirth alone and stillbirth with first or second trimester loss.